A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
05 02 2019
Historique:
entrez: 7 2 2019
pubmed: 7 2 2019
medline: 6 4 2019
Statut: epublish

Résumé

Encephalomyocarditis virus (EMCV) is a picornavirus that produces lytic infections in murine and human cells. Employing a genome-wide CRISPR-Cas9 knockout screen to find host factors required for EMCV infection, we identified a role for ADAM9 in EMCV infection. CRISPR-mediated deletion of ADAM9 in multiple human cell lines rendered the cells highly resistant to EMCV infection and cell death. Primary fibroblasts from ADAM9 KO mice were also strongly resistant to EMCV infection and cell death. In contrast, ADAM9 KO and WT cells were equally susceptible to infection with other viruses, including the picornavirus Coxsackie virus B. ADAM9 KO cells failed to produce viral progeny when incubated with EMCV. However, bypassing EMCV entry into cells through delivery of viral RNA directly to the cytosol yielded infectious EMCV virions from ADAM9 KO cells, suggesting that ADAM9 is not required for EMCV replication post-entry. These findings establish that ADAM9 is required for the early stage of EMCV infection, likely for virus entry or viral genome delivery to the cytosol.

Identifiants

pubmed: 30723129
pii: mBio.02734-18
doi: 10.1128/mBio.02734-18
pmc: PMC6428755
pii:
doi:

Substances chimiques

Membrane Proteins 0
ADAM Proteins EC 3.4.24.-
ADAM9 protein, human EC 3.4.24.-
Adam9 protein, mouse EC 3.4.24.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI091786
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111475
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116920
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI095213
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Bazzone et al.

Références

J Cell Sci. 1999 Nov;112 ( Pt 21):3603-17
pubmed: 10523497
J Biol Chem. 1999 Oct 29;274(44):31693-9
pubmed: 10531379
J Cell Sci. 2000 Jun;113 ( Pt 12):2319-28
pubmed: 10825303
Genes Dev. 2000 Aug 15;14(16):2028-45
pubmed: 10950867
Mol Cell Biol. 2002 Mar;22(5):1537-44
pubmed: 11839819
Biochem Biophys Res Commun. 2002 May 3;293(2):800-5
pubmed: 12054541
Genes Dev. 2003 Jan 1;17(1):7-30
pubmed: 12514095
Science. 2003 Aug 1;301(5633):640-3
pubmed: 12855817
Proc Soc Exp Biol Med. 1963 Nov;114:500-3
pubmed: 14104611
Science. 1960 Feb 19;131(3399):498-9
pubmed: 14425363
Immunology. 2003 Dec;110(4):519-26
pubmed: 14632651
Vet Res. 2004 Jan-Feb;35(1):113-22
pubmed: 15099508
Wien Klin Wochenschr. 2003;115 Suppl 3:61-7
pubmed: 15508783
Nat Rev Mol Cell Biol. 2005 Jan;6(1):32-43
pubmed: 15688065
Dev Biol. 2005 Jul 15;283(2):459-71
pubmed: 15936750
Epidemiol Infect. 2005 Jun;133(3):547-57
pubmed: 15962562
Cancer Res. 2005 Oct 15;65(20):9312-9
pubmed: 16230393
Am J Physiol Cell Physiol. 2006 Jul;291(1):C1-10
pubmed: 16769815
Arch Pathol. 1975 Aug;99(8):424-9
pubmed: 167704
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12417-22
pubmed: 16888036
Vet Res. 2006 Nov-Dec;37(6):757-66
pubmed: 16973116
Acta Neuropathol. 1975 Aug 11;32(2):133-42
pubmed: 170775
Aust Vet J. 1975 Sep;51(9):409-15
pubmed: 173273
Aust Vet J. 1975 Sep;51(9):416-22
pubmed: 173274
RNA. 2007 Aug;13(8):1366-74
pubmed: 17592045
EMBO J. 2007 Sep 5;26(17):3936-44
pubmed: 17690690
Science. 1945 Jul 13;102(2637):31-3
pubmed: 17787415
Br J Cancer. 2008 Mar 25;98(6):1132-40
pubmed: 18283314
Cancer Lett. 2008 Jul 8;265(2):298-306
pubmed: 18355957
Mol Cancer Ther. 2008 Oct;7(10):3176-86
pubmed: 18852121
BMC Cell Biol. 2008 Dec 18;9:69
pubmed: 19094237
Mol Cell Biol. 2009 May;29(10):2694-703
pubmed: 19273593
Emerg Infect Dis. 2009 Apr;15(4):640-6
pubmed: 19331761
J Wildl Dis. 2009 Apr;45(2):522-6
pubmed: 19395765
Am J Hum Genet. 2009 May;84(5):683-91
pubmed: 19409519
Blood. 2009 Jul 2;114(1):e10-9
pubmed: 19436052
Cell. 2009 Dec 24;139(7):1243-54
pubmed: 20064371
Virol J. 2010 Mar 18;7:64
pubmed: 20298561
J Clin Invest. 1947 Nov;26(6):1197
pubmed: 20340975
Am J Trop Med Hyg. 1978 Jan;27(1 Pt 1):144-9
pubmed: 204206
Vector Borne Zoonotic Dis. 2011 Apr;11(4):367-74
pubmed: 21395427
Arch Virol. 2012 Jan;157(1):43-52
pubmed: 21989795
Mol Syst Biol. 2011 Nov 08;7:548
pubmed: 22068331
Eur J Cell Biol. 2012 Jun-Jul;91(6-7):472-85
pubmed: 22138087
Virulence. 2012 Jul 1;3(4):351-67
pubmed: 22722247
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
J Virol. 2014 Mar;88(6):3369-78
pubmed: 24390337
J Immunol. 2014 Sep 1;193(5):2469-82
pubmed: 25063875
Cytokine Growth Factor Rev. 2014 Oct;25(5):577-85
pubmed: 25086453
Mol Cell Proteomics. 2014 Dec;13(12):3435-45
pubmed: 25205226
Med J Aust. 1989 Aug 7;151(3):176, 178
pubmed: 2547141
J Leukoc Biol. 2015 May;97(5):951-962
pubmed: 25765677
J Biol Chem. 2015 May 8;290(19):12135-46
pubmed: 25795784
Cell Rep. 2015 Jul 28;12(4):673-83
pubmed: 26190106
J Mol Cell Cardiol. 2016 Apr;93:186-99
pubmed: 26522853
Adv Virus Res. 2016;94:1-51
pubmed: 26997589
Toxins (Basel). 2016 May 17;8(5):
pubmed: 27196928
Cell Rep. 2016 Jun 28;16(1):232-246
pubmed: 27342126
Nature. 2016 Jul 7;535(7610):164-8
pubmed: 27383988
Mediators Inflamm. 2017;2017:9621724
pubmed: 28260841
Biochem J. 2017 Jun 9;474(12):2051-2065
pubmed: 28487378
Cell Rep. 2017 Aug 15;20(7):1503-1512
pubmed: 28813663
Biochem Biophys Res Commun. 2017 Nov 18;493(2):1057-1062
pubmed: 28928095
Sci Rep. 2017 Nov 8;7(1):15108
pubmed: 29118335
J Cell Sci. 2018 Jan 4;131(1):
pubmed: 29142101
Cell Rep. 2018 Apr 10;23(2):596-607
pubmed: 29642015
Curr Opin Virol. 2018 Apr;29:87-100
pubmed: 29684735
J Virol. 1994 Jun;68(6):3453-8
pubmed: 7514674
J Virol. 1994 Nov;68(11):7308-19
pubmed: 7933115
Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2748-51
pubmed: 8146185
J Cell Biol. 1996 Feb;132(4):717-26
pubmed: 8647900
J Zoo Wildl Med. 1997 Jun;28(2):153-7
pubmed: 9279403
J Biol Chem. 1998 Feb 13;273(7):4180-7
pubmed: 9461614
J Biol Chem. 1999 Feb 5;274(6):3531-40
pubmed: 9920899

Auteurs

Lindsey E Bazzone (LE)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Michael King (M)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Christopher R MacKay (CR)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Pyae P Kyawe (PP)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Paul Meraner (P)

Department of Microbiology and Physiological Systems (MaPS), University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Daniel Lindstrom (D)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Joselyn Rojas-Quintero (J)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Caroline A Owen (CA)

Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Jennifer P Wang (JP)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Program in Innate Immunity, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Abraham L Brass (AL)

Department of Medicine, Division of Gastroenterology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Peak Gastroenterology Associates, Colorado Springs, Colorado, USA.

Evelyn A Kurt-Jones (EA)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA Evelyn.Kurt-Jones@umassmed.edu Robert.Finberg@umassmed.edu.
Program in Innate Immunity, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Robert W Finberg (RW)

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA Evelyn.Kurt-Jones@umassmed.edu Robert.Finberg@umassmed.edu.
Program in Innate Immunity, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH